Strongyloidiasis clinical trials
The registry lists 15 studies for Strongyloidiasis across more than 10 countries. 2 are recruiting or about to start. 7 of them are mainly about Strongyloidiasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-07.
Get an email when these change. Save the Strongyloidiasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Swiss Tropical & Public Health Institute (2) · Mahidol University (1) · Albert Einstein College of Medicine (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Imperial College Healthcare NHS Trust (1) · London School of Hygiene and Tropical Medicine (1) · Barcelona Institute for Global Health (1) · IRCCS Sacro Cuore Don Calabria di Negrar (1)
What is being tested here
Drugs under test in Strongyloidiasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Ivermectin | 0 | 4 | 4 |
| Emodepside | 0 | 0 | 1 |
| Azithromycin | 0 | 1 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2, phase 3 first
- Feb 2027Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras · Phase 3 · Mundo Sano Foundation
- Jun 2027Better Options for Lymphatic Filariasis Treatment · Phase 3 · Medicines Development for Global Health
Who these studies take
Of the 1 Strongyloidiasis studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (100%) | 1 (100%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 15 studies, recruiting or not: 27% stop at 75 or younger and 27% at 65; 60% take children; 0% are for women only and 0% for men only; 40% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 15 of 15. search them.
- Better Options for Lymphatic Filariasis TreatmentRecruitingNCT07159373Phase 31 country
- Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in HondurasNot yet recruitingNCT07661316Phase 31 country
- Strongyloidiasis at CHRU Nancy: Evaluation of the Performance of Serological Tests and Disease-associated CharacteristicsCompletedNCT072961981 country
- Delivering a Multi-disease Screening Tool to Migrant PopulationsCompletedNCT05868005Not applicable1 country
- Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis StercoralisCompletedNCT06373835Phase 21 country
- Treatment of Strongyloides InfectionTerminatedNCT03605758Phase 31 country
- Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy StudyCompletedNCT049997741 country
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownNCT04844905Phase 31 country
- Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UKStatus unknownNCT04709848
- Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )CompletedNCT03676140Phase 31 country
- Multiple Versus Single Dose of Ivermectin for the Treatment of StrongyloidiasisCompletedNCT01570504Phase 33 countries
- Ivermectin Versus Albendazole for Chronic StrongyloidiasisCompletedNCT00765024Phase 31 country
- Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive DisordersCompletedNCT021057144 countries
- Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT000012451 country
- Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm InfectionsCompletedNCT00207753Not applicable1 country